Surgery Partners, Inc. SGRY
23.13 USD +0.01 (+0.04%)
At closeNov 3, 2026, 6:30 PM EST
23.13 0.00 0.00%
After hours · Nov 3, 6:30 PM ET
23.12 Day range 23.22
11.41 52-week range 23.37
- YTD
- +49.71%
- 1 year
- +6.59%
- Market cap
- 2.98B
- Revenue (ttm)
- 3.37B
- Profit margin
- -2.63%
- EPS (ttm)
- -0.69
- Shares out
- 128.87M
- Forward P/E
- 111.12
- YTD return
- +49.71%
- 1-year return
- +6.59%
- Volume
- 2.39M
- Avg volume
- 3.40M
- Open
- 23.19
- Previous close
- 23.12
- Day's range
- 23.12 – 23.22
- 52-week range
- 11.41 – 23.37
- Beta
- 1.88
- Analysts
- Buy
- Price target
- 21.70 (-6.2%)
- Earnings date
- Nov 9, 2026
2Y -6.09 (-20.84%)
Key statistics
- Enterprise value
- 8.65B
- PEG ratio
- 0.00
- Price / sales
- 0.89
- Price / book
- 1.80
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 2.70%
- Free cash flow
- 183.56M
- Total cash
- 216.70M
- Total debt
- 4.07B
- Return on equity
- 2.32%
- Short % of float
- 21.69%
- 50-day average
- 15.30
- 200-day average
- 14.66
Analyst view
Consensus: buy
Buy
Price target (mean) 21.70 -6.2% downside
Now 23.13
- Target (low)
- 19.00
- Target (mean)
- 21.70
- Target (high)
- 23.50
Ratings (0m) 7 2 buy · 5 hold · 0 sell
- Strong buy0
- Buy2
- Hold5
- Sell0
- Strong sell0
Next earnings
Nov 9, 2026
Expected Nov 9, 2026. Consensus EPS estimate 0.12467.
Financials — quick view
SGRY Revenue — quarterly 848.90M
SGRY Net income — quarterly -15.00M
SGRY EPS — quarterly -0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 9, 2026 | Sep 30, 2026 | 0.1106 | — | — | — |
| Aug 10, 2026 | Jun 30, 2026 | 0.05794 | 0.10 | +0.04 | +72.59% |
| May 5, 2026 | Mar 31, 2026 | -0.15 | -0.03 | +0.12 | +80.00% |
| Mar 2, 2026 | Dec 31, 2025 | 0.31 | 0.12 | -0.19 | -61.29% |
| Nov 10, 2025 | Sep 30, 2025 | 0.19 | 0.13 | -0.06 | -31.58% |
| Aug 5, 2025 | Jun 30, 2025 | 0.16 | 0.17 | +0.01 | +6.25% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | UBS | down | Buy | Neutral |
| Oct 27, 2026 | StoneX | down | Buy | Hold |
| Sep 30, 2026 | RBC Capital | reit | Outperform | Outperform |
| Sep 18, 2026 | TD Cowen | reit | Buy | Buy |
| Sep 14, 2026 | JP Morgan | main | Neutral | Neutral |
| Aug 11, 2026 | TD Cowen | main | Buy | Buy |
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- surgerypartners.com
News
INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - RRC, SGRY, BOLT and PCRX - IS IT A FAIR DEAL FOR YOU? 
SGRY Shareholder Notice: Surgery Partners $23.50 per Share Merger Under Investigation on Behalf of Shareholders 
SURGERY PARTNERS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Surgery Partners, Inc.'s Directors for Breach of Fiduciary Duties – SGRY 
SGRY Legal Notice: Surgery Partners Shareholders Are Notified to Contact BFA Law About the Ongoing Investigation Into the $23.50 Per Share Merger 
SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares 
SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger 
UBS Downgrades Surgery Partners to Neutral, Raises Price Target to $23.5 
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Surgery Partners, Inc. (NASDAQ: SGRY) 
Surgery Partners Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surgery Partners, Inc. - SGRY 
SGRY Stock Notification: Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
Your note
Sign in to keep a note on SGRY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BALDOCK JENNIFER BOYD | Officer | Sale | Mar 11, 2026 | 326,474 |
| BANE HARRISON R | Officer | Sale | Sep 3, 2025 | 117,181 |
| BRITTENHAM MARISSA | Officer | Sale | Mar 12, 2026 | 94,196 |
| BURKHALTER DANIELLE | Officer | Sale | Mar 12, 2026 | 76,864 |
| DEVEYDT WAYNE S | Officer and Director | Stock Award(Grant) | Mar 20, 2025 | 105,203 |
| DOHERTY DAVID T. | Chief Financial Officer | Sale | Mar 15, 2026 | 221,679 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Investors Llc | 38.15% | 49,946,972 | 1.16B | Jun 29, 2026 |
| Jupiter Topco LLC | 10.60% | 13,882,155 | 321.09M | Jun 29, 2026 |
| Pentwater Capital Management Lp | 8.88% | 11,630,000 | 269.00M | Jun 29, 2026 |
| UBS Group AG | 6.55% | 8,573,413 | 198.30M | Jun 29, 2026 |
| Blackrock Inc. | 4.77% | 6,241,503 | 144.37M | Jun 29, 2026 |
| King Street Capital Management, LP | 4.63% | 6,058,141 | 140.12M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund | 10.13% | 13,258,236 | 306.66M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.90% | 2,481,034 | 57.39M | Jun 29, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1.60% | 2,097,590 | 48.52M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.58% | 2,063,090 | 47.72M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.37% | 1,798,439 | 41.60M | Jun 29, 2026 |
| Legg Mason Partners Investment Trust-ClearBridge Select Fund | 1.22% | 1,594,774 | 36.89M | Jul 30, 2026 |